Young Investigator Awards

• 18F Labeled benzamides for pre-clinical PET imaging of melanoma
• Combining an MDM2 inhibitor with chemotherapy for the treatment of melanoma
• The role of oncogenic signaling pathways in human melanoma immune evasion

Established Investigator Awards

• Targeting signaling pathways for therapy in a new mouse model of melanoma
• Development of intra-tumoral prognostic biomarkers for primary melanoma
• Treatment of melanoma combining cancer gene therapy and immunotherapy
• A phase I trial of bevacizumab plus ipilimumab in melanoma patients
• Targeting the IGF1R pathway in melanoma
• Targeted strategy for treatment of melanoma

Pilot Awards

• Sulforaphane, a melanoma prevention agent for high-risk MC1R genotypes
• Mechanisms of melanoma treatment resistance
• Treatment of established melanoma by tumor-specific Th17 cells
  

Development Award

• Transcriptome sequencing to detect gene fusions in melanoma
  
  

Science Awards

• Developing Melanoma Screening in Primary Care
• Manipulating Immune Regulation in Adoptive T-cell Therapy for Melanoma
• Identification and Validation of Combination Therapies for Melanomas
• Sequencing of the Melanoma Exome, Transcriptome and Epigenome
• ombinatorial Immunotherapy for Melanoma with B7-H1/PD-1 Checkpoint Blockade
• Identification of Novel Melanoma Risk Genes Using High-throughput Genomics
• Defining the Importance of Immunity to NY-ESO-1 in Melanoma